©The Author(s) 2026.
World J Gastroenterol. Feb 28, 2026; 32(8): 115675
Published online Feb 28, 2026. doi: 10.3748/wjg.v32.i8.115675
Published online Feb 28, 2026. doi: 10.3748/wjg.v32.i8.115675
Figure 3 Treatment with a dipeptidyl peptidase 4 inhibitor increases C-C motif chemokine ligand 16 expression and immune cell infiltration in the tumor microenvironment.
DPP-4: Dipeptidyl peptidase 4; CCL: C-C motif chemokine ligand; STAT: Signal transduction and transcription activation; JAK: Janus kinase; IL: Interleukin; TAMs: Tumor-associated macrophages; HCC: Hepatocellular carcinoma.
- Citation: Yang M, Zhang CY. Molecular mechanisms of tumor-associated macrophages in hepatocellular carcinoma development and therapy. World J Gastroenterol 2026; 32(8): 115675
- URL: https://www.wjgnet.com/1007-9327/full/v32/i8/115675.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i8.115675